UNLIMITED TURBO LONG - MERCK & CO. | Market Closed - Borsa Italiana 16:04:59 2024-06-14 EDT | ||
| 4.4 EUR | 0.00% |
|
| Current month | +10.20% | ||
| 1 month | +1.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 4.43 | +0.68% |
| 24-06-13 | 4.4 | -2.00% |
| 24-06-12 | 4.49 | -3.65% |
| 24-06-11 | 4.66 | +1.30% |
| 24-06-10 | 4.6 | +2.00% |
Real-time Borsa Italiana
Last update June 14, 2024 at 04:04 pm
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| P1AL56 | |
| ISIN | NLBNPIT1AL56 |
| Date issued | 2022-04-05 |
| Strike | 89.58 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.95 € |
|---|---|
| Lowest since issue | 1.086 € |
| Spread | 0.01 € |
| Spread % | 0.23% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5
USD
Average target price
142.7
USD
Spread / Average Target
+10.20%
- Stock Market
- Certificates
- P1AL56 Certificat
